Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma (Q45204211)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma |
scientific article published in March 2005 |
Statements
1 reference
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma (English)
1 reference
Visani G
1 reference
Guiducci B
1 reference
D'Adamo F
1 reference
Mele A
1 reference
Nicolini G
1 reference
Leopardi G
1 reference
Sparaventi G
1 reference
Barulli S
1 reference
Malerba L
1 reference
Isidori A
1 reference
Malagola M
1 reference
Piccaluga PP
1 reference
1 March 2005
1 reference
1 reference
46
1 reference
3
1 reference
477-479
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference